acid fuchsin has been researched along with Disease Models, Animal in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andreana, S; Cornelini, R; Covani, U; Piattelli, A; Piattelli, M; Quaranta, A; Scarano, A | 1 |
| Agarwal, R; Botez, G; Rami, A; Winckler, J | 1 |
2 other study(ies) available for acid fuchsin and Disease Models, Animal
| Article | Year |
|---|---|
Effect of enamel matrix derivative (Emdogain) on bone defects in rabbit tibias.
Topics: Animals; Benzenesulfonates; Bone Diseases; Bone Matrix; Bone Regeneration; Bone Substitutes; Coloring Agents; Dental Enamel Proteins; Disease Models, Animal; Osteoblasts; Rabbits; Rosaniline Dyes; Tibia; Time Factors; Tolonium Chloride; Wound Healing | 2004 |
mu-Calpain activation, DNA fragmentation, and synergistic effects of caspase and calpain inhibitors in protecting hippocampal neurons from ischemic damage.
Topics: Amino Acid Chloromethyl Ketones; Animals; Apoptosis; Benzenesulfonates; Brain Ischemia; Calpain; Caspase Inhibitors; Caspases; Coloring Agents; Cysteine Proteinase Inhibitors; Disease Models, Animal; DNA Fragmentation; Drug Combinations; Drug Synergism; Glycoproteins; Hippocampus; Immunohistochemistry; In Situ Nick-End Labeling; Male; Neurons; Neuroprotective Agents; Oxazines; Rats; Rats, Wistar; Reperfusion Injury | 2000 |